Choosing anesthesia type during deep brain stimulation for Parkinson’s
Part of Brain & nervous system clinical trials.
This study compares different anesthesia choices during deep brain stimulation surgery for Parkinson’s disease, using a technique that guides electrode placement. It may help your care team choose the safest and most comfortable anesthesia approach for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your age is 50 to 80 years old
- You are in ASA class II to III (a general health category used before anesthesia)
- You have Parkinson’s disease and will receive DBS on both sides of the subthalamic nucleus (STN)
- You can and will sign informed consent to join the study
- You do not have certain health issues that could make anesthesia riskier
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a drug called esketamine (related to ketamine) can help make the anesthesia experience better for people with Parkinson's disease who are undergoing a specific brain surgery called bilateral STN-DBS. If you qualify, you would receive esketamine during your procedure to see if it improves outcomes.
This study looks at how deep brain stimulation (DBS) affects sleep problems in people with Parkinson's disease. It aims to understand brain changes and improve sleep quality.
This study is for people with Parkinson's disease who need to have their deep brain stimulator (a device that sends electrical pulses to control movement) replaced or adjusted. The researchers want to learn the best way to do this procedure safely.
This study looks at a sleep-focused approach to brain stimulation (DBS) in people with Parkinson’s disease. You may be able to join if you’re planning or scheduled for specific DBS surgery at the University of Minnesota and have the needed brain imaging.
This study looks at how the placement of electrodes during deep brain stimulation (DBS) for Parkinson's disease affects recovery and motor symptoms right after surgery. It could help doctors improve DBS outcomes for people with Parkinson's.
This study looks at factors that predict how well deep brain stimulation (DBS) works for people with Parkinson's disease. If you are considering DBS, joining this research could help doctors better understand who benefits most from the procedure.
Hear when a new Dexmedetomidine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.